Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in MDS and AML patients: Phase Ib results. This is an ASCO Meeting Abstract from the 2020 ASCO ...
Objective To examine the effect of gender affirming hormones on athletic performance among transwomen and transmen. Methods We reviewed fitness test results and medical records of 29 transmen and 46 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results